Farmakoterapie obezity - Eisnerová, Kristýna (Acta medicinae, 2021)
Keywords: Bupropion; Naltrexone; Phentermine; naltrexon; Heart Disease Risk Factors; Diet, Reducing; Obesity; lidé; glukagonu podobný peptid 1; Hypoglycemic Agents; Humans; hypoglykemika; bupropion; liraglutid; obezita; redukční dieta; Orlistat; Glucagon-Like Peptide 1; Liraglutide; dulaglutid; orlistat; rizikové faktory kardiovaskulárních chorob; fentermin